Posts

Showing posts with the label diabetes mellitus

Lantrida: US FDA Approves First Cellular Therapy to Treat Patients with Type 1 Diabetes

A historic milestone was set on June 28, 2023, when the U.S. Food and Drug Administration (FDA) granted approval for Lantidra to CellTrans, Inc., a company headquartered in Chicago, Illinois. Lantidra is a groundbreaking allogeneic pancreatic islet cellular therapy derived from the pancreatic cells of deceased donors. This landmark decision made it the world’s first cellular therapeutic to be approved for the treatment of type 1 diabetes, a disease that does not yet have a permanent treatment option. Lantridra is designed specifically for adults who have difficulty achieving target glycated hemoglobin levels due to recurring episodes of severe hypoglycemia. “Severe hypoglycemia is a dangerous condition that can lead to injuries resulting from loss of consciousness or seizures,” said Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research. “Today’s approval, the first-ever cell therapy to treat patients with type 1 diabetes, provides individuals li...

Stem Cell Therapy for Diabetes in Singapore 2022

Image
Researchers are working on using embryonic stem cell therapy to treat type 1 diabetes, which happens when the immune system destroys the beta cells in the pancreas that make insulin. Researchers have found a way to turn human embryonic stem cells into ones known as pancreatic progenitor cells. These can then mature into insulin-making beta cells. Majority of stem cell research for diabetes is concentrated on Type 1 diabetes as it can be traced to the loss of a single cell type, the beta islet cell. Beta cells (β cells) are a type of cell found in pancreatic islets that produce and secrete insulin. In patients with type I or type II diabetes, beta-cell mass and function are diminished, leading to insufficient insulin secretion and high blood sugar. Currently, two approaches are being used in research, using stem cells as beta-cell producing factories or as a beta cell repair catalyst. Both methods have the same goal which is to return the insulin to normal levels.  Diabetes ...

Listing of Diseases Treated with Stem Cells: Parent's Guide to Cord Blood

Image
Diseases treated with cord blood can be divided into 2 categories: Proven Standard Therapies Therapies in Clinical Trials Before choosing the right form of cord blood banking it is also important to distinguish between two modes of treatment: Allogeneic - patient receives stem cells from a matching donor, either a sibling or an unrelated donor Autologous - patient receives their own stem cells When parents donate cord blood to a public bank, they are supporting patients around the world who are searching for an unrelated Allogeneic donor. When parents save cord blood in a family bank, they are reserving the options that the baby can use its own stem cells for an Autologous treatment, or an immediate relative (sibling or parents) can use the stem cells for an Allogeneic treatment. Standard Therapies with blood-forming stem cells These are diseases for which transplants of blood-forming stem cells (Hematopoietic Stem Cell Transplants, HSCT) are a standard treatment. F...

Stem Cell Treatment for Diabetes in Malaysia 2020: Review and Price

Image
In recent years, stem cell therapy has gained popularity as a promising alternative treatment option for diabetes mellitus. However, there is also a lot of confusion due to the overwhelming mixing of credible scientific information and marketing hypes available on the internet. We have compiled and summarised essential information below in layman's terms so that you can understand and make a better informed decision. What are Stem Cells? Stem cells  can be viewed as master cells that can give rise to all types of cells in the body. Generally, stem cells are classified as unipotent, multi-potent or pluripotent according to their potential to differentiate. Stem cells can also be classified based on their source, for example, embryonic stem cells, foetal stem cells and adult stem cells. Stem cells differ from other kinds of cells in the body. They are special because of their ability to self-renew, duplicate, regenerate and repair. Stem cells have two important properties...

Insulin-producing Beta Cell Transplants for Type 1 Diabetes see near-normal glucose levels without insulin after ten years

Image
American Diabetes Association's 79th Scientific Sessions - A group of adults with type 1 diabetes that have not needed insulin for an average of 10 years and are maintaining near normal blood glucose thanks to islet cell transplantation, a new study shows. Islet transplantation is where isolated islets - groups of insulin-producing beta cells from the pancreas - from a donor are transplanted. Researchers from University of Miami's Diabetes Research Institute used continuous glucose monitoring to track the performance of the transplants in five people with type 1 diabetes. The results showed trends in glucose level control, which were near normal, as well as close to perfect time-in-range metrics. The participants were given islet transplants into the liver (intrahepatic islet transplant) from 2002 and 2010 and were then insulin independent for between seven and more than 16 years. Researchers carried out a seven-day assessment with the participants wearing continu...